Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2− Breast Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2− Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 4, Pages 526
Publisher
MDPI AG
Online
2019-04-13
DOI
10.3390/cancers11040526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Factors Predictive of Response to Hormone Therapy in Breast Cancer
- (2018) Francesca Rastelli et al. TUMORI
- PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining
- (2017) So Yamaki et al. International Journal of Clinical Oncology
- Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness
- (2017) Kohsuke Gonda et al. Scientific Reports
- Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer
- (2016) Eylem Kulkoyluoglu et al. STEROIDS
- Quantitative diagnosis of HER2 protein expressing breast cancer by single-particle quantum dot imaging
- (2016) Minoru Miyashita et al. Cancer Medicine
- Extranuclear Steroid Receptors Are Essential for Steroid Hormone Actions
- (2015) Ellis R. Levin Annual Review of Medicine
- The changing role of ER in endocrine resistance
- (2015) Agostina Nardone et al. BREAST
- The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
- (2015) Richard S Finn et al. LANCET ONCOLOGY
- Predictive diagnosis of the risk of breast cancer recurrence after surgery by single-particle quantum dot imaging
- (2015) Kohsuke Gonda et al. Scientific Reports
- ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†
- (2014) F. Cardoso et al. ANNALS OF ONCOLOGY
- The therapeutic target of estrogen receptor-alpha36 in estrogen-dependent tumors
- (2014) Yu Gu et al. Journal of Translational Medicine
- Hexokinase II in breast carcinoma: A potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67
- (2013) Akiko Sato-Tadano et al. CANCER SCIENCE
- Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
- (2013) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- Development of a quantitative diagnostic method of estrogen receptor expression levels by immunohistochemistry using organic fluorescent material-assembled nanoparticles
- (2012) Kohsuke Gonda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Mechanisms of Resistance to Endocrine Therapy in Breast Cancer: Focus on Signaling Pathways, miRNAs and Genetically Based Resistance
- (2012) Rocío García-Becerra et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
- (2012) Thomas Bachelot et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance of Progesterone Receptor–Positive Tumor Cells Within Immunohistochemically Defined Luminal A Breast Cancer
- (2012) Aleix Prat et al. JOURNAL OF CLINICAL ONCOLOGY
- Palmitoylation Regulates 17β-Estradiol-Induced Estrogen Receptor-α Degradation and Transcriptional Activity
- (2012) Piergiorgio La Rosa et al. MOLECULAR ENDOCRINOLOGY
- Comparison of immunohistochemical analysis with estrogen receptor SP1 and 1D5 monoclonal antibodies in breast cancer
- (2012) Klesia Pirola Madeira et al. PATHOLOGY RESEARCH AND PRACTICE
- Quantum dots-based molecular classification of breast cancer by quantitative spectroanalysis of hormone receptors and HER2
- (2011) Chuang Chen et al. BIOMATERIALS
- Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer
- (2011) Emi Tokuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Cytoplasmic Estrogen Receptor in Breast Cancer
- (2011) A. W. Welsh et al. CLINICAL CANCER RESEARCH
- The quantitative detection of total HER2 load by quantum dots and the identification of a new subtype of breast cancer with different 5-year prognosis
- (2010) Chuang Chen et al. BIOMATERIALS
- Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors
- (2009) Hugo Arias-Pulido et al. GYNECOLOGIC ONCOLOGY
- Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
- (2009) Liang Shi et al. JOURNAL OF CLINICAL ONCOLOGY
- Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial
- (2008) George Pentheroudakis et al. BREAST CANCER RESEARCH AND TREATMENT
- Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry
- (2008) Rafael Rocha et al. PATHOLOGY RESEARCH AND PRACTICE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started